Guanine

Guanine

SCHEMBL8090344

Nc1nc2nc[nH]c2c(=O)[nH]1.O=c1[nH]c(=O)c2[nH]cnc2[nH]1.O=c1[nH]c(=S)c2[nH]cnc2[nH]1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNP P00491 2/20 0.65
GDA Q9Y2T3 2/20 0.57
ACHE P22303 1/20 0.57
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
USP2 O75604 1/20 0.47
TP53 P04637 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
PTGS1 P23219 1/20 0.47
MAPK3 P27361 1/20 0.47
XDH P47989 1/20 0.47
HBB P68871 1/20 0.47
PAX8 Q06710 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
THRB P10828 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Guanine SCHEMBL72148 0.92 PNP (0.77) PNPGDAACHEALDH1A1HPGD
Guanine SCHEMBL28135092 0.91 PNP (0.74) PNPGDAACHEALDH1A1HPGD
Guanine SCHEMBL629581 0.90 PNP (0.72) PNPGDAACHEALDH1A1HPGD
Guanine SCHEMBL28018185 0.86 PNP (0.67) PNPGDAACHEALDH1A1HPGD
Guanine SCHEMBL28068968 0.84 PNP (0.63) PNPGDAACHEALDH1A1HPGD
Guanine SCHEMBL28067184 0.83 PNP (0.79) PNPGDAALDH1A1HPGDUSP2
Guanine SCHEMBL1264884 0.81 PNP (1.00) PNPGDAALDH1A1HPGDMAPT
Guanine SCHEMBL986801 0.81 PNP (1.00) PNPGDAALDH1A1HPGDMAPT
Guanine SCHEMBL5260 0.81 PNP (1.00) PNPGDAALDH1A1HPGDMAPT
Guanine SCHEMBL22533907 0.79 PNP (0.96) PNPGDAALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1053022-A2 SENSITIZING CELLS TO COMPOUNDS USING LIPID-MEDIATED GENE AND COMPOUND DELIVERY Inex Pharmaceuticals Corp. (CA) 2000-11-22 EP disclosed
WO-1999039740-A9 SENSITIZING CELLS TO COMPOUNDS USING LIPID-MEDIATED GENE AND COMPOUND DELIVERY INEX PHARMACEUTICALS CORP (CA) 1999-11-25 WO disclosed
WO-1999039740-A2 SENSITIZING CELLS TO COMPOUNDS USING LIPID-MEDIATED GENE AND COMPOUND DELIVERY INEX PHARMACEUTICALS CORPORATION (CA) 1999-08-12 WO disclosed